Abbott India Ltd.
| BSE: 500488 | Sector: Health care |
| NSE: ABBOTINDIA | ISIN Code: INE358A01014 |
| BSE 00:00 | 17 May | 17635.70 |
1106.50 (6.69%) |
OPEN
16470.10 |
HIGH
17801.85 |
LOW
16435.90 |
| NSE 00:00 | 17 May | 17636.10 |
1135.85 (6.88%) |
OPEN
16499.60 |
HIGH
17838.00 |
LOW
16439.20 |
| OPEN | 16470.10 |
| PREVIOUS CLOSE | 16529.20 |
| VOLUME | 1943 |
| 52-Week high | 23902.30 |
| 52-Week low | 15525.00 |
| P/E | 50.66 |
| Mkt Cap.(Rs cr) | 37,476 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Abbott India Ltd. (ABBOTINDIA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 536.05 | -14.70 | -2.67 | 15823.68 |
| Cipla | 938.00 | 4.90 | 0.53 | 13900.58 |
| Dr Reddy's Labs | 3904.10 | 16.85 | 0.43 | 13349.10 |
| Sun Pharma.Inds. | 892.05 | 6.30 | 0.71 | 12803.21 |
| Lupin | 691.40 | 6.75 | 0.99 | 11055.93 |
| Apollo Hospitals | 3812.85 | 124.65 | 3.38 | 9153.00 |
| Zydus Lifesci. | 349.05 | 3.90 | 1.13 | 7790.40 |
| Glenmark Pharma. | 402.25 | 9.75 | 2.48 | 7567.93 |
| Alkem Lab | 2903.70 | 1.80 | 0.06 | 7219.68 |
| Divi's Lab. | 4302.25 | 82.70 | 1.96 | 6798.61 |
| Torrent Pharma. | 2617.75 | 33.30 | 1.29 | 6450.83 |
| Ipca Labs. | 988.75 | 4.85 | 0.49 | 5114.11 |
| Alembic Pharma | 747.60 | 7.70 | 1.04 | 5051.44 |
| Laurus Labs | 559.10 | 16.80 | 3.10 | 4768.72 |
| Abbott India | 17635.70 | 1106.50 | 6.69 | 4310.02 |
| Gland Pharma | 3105.45 | -4.20 | -0.14 | 3462.88 |
| Glaxosmi. Pharma | 1517.20 | 3.10 | 0.20 | 3193.74 |
| Granules India | 250.50 | 8.35 | 3.45 | 3134.98 |
| Sanofi India | 6602.40 | -4.70 | -0.07 | 2956.60 |
| Ajanta Pharma | 1706.40 | 22.80 | 1.35 | 2718.59 |
Quick Links for Abbott India:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
